{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:24:49Z","timestamp":1790735089259,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Federal Work Study Program"},{"name":"Baylor College of Medicine"},{"name":"BrightFocus Foundation Alzheimer\u2019s Disease","award":["A2010097"],"award-info":[{"award-number":["A2010097"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.neuroscience.2014.11.051","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T18:51:38Z","timestamp":1417719098000},"page":"251-263","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Seizures in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"286","author":[{"given":"H.A.","family":"Born","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2014.11.051_b0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1468-1331.2007.01664.x","article-title":"Dementia, delusions and seizures: storage disease or genetic AD?","volume":"14","author":"Alberici","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1525-5069(02)00500-5","article-title":"Treatment of psychosis, aggression, and irritability in patients with epilepsy","volume":"3","author":"Alper","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","article-title":"Incidence and predictors of seizures in patients with Alzheimer\u2019s disease","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.47.3.626","article-title":"Reversible parkinsonism and cognitive impairment with chronic valproate use","volume":"47","author":"Armon","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0030","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-1331.2007.01907.x","article-title":"Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study","volume":"14","author":"Belcastro","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0035","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","article-title":"The amyloid pathology progresses in a neurotransmitter-specific manner","volume":"27","author":"Bell","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0040","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2014.03.029","article-title":"Bexarotene reduces network excitability in models of Alzheimer\u2019s disease and epilepsy","volume":"35","author":"Bomben","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0045","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1523\/JNEUROSCI.5171-13.2014","article-title":"Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzeimer\u2019s disease","volume":"34","author":"Born","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0050","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0055","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"321","author":"Busche","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0060","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/brain\/awl237","article-title":"Phenotype associated with APP duplication in five families","volume":"129","author":"Cabrejo","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0065","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1242\/dev.01103","article-title":"Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone","volume":"131","author":"Caill\u00e9","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0070","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/00001756-199607080-00009","article-title":"A novel presenilin 1 mutation resulting in familial Alzheimer\u2019s disease with an onset age of 29years","volume":"7","author":"Campion","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0075","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0080","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","article-title":"Myoclonus: current concepts and recent advances","volume":"3","author":"Caviness","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yebeh.2012.11.040","article-title":"Shared cognitive and behavioral impairments in epilepsy and Alzheimer\u2019s disease and potential underlying mechanisms","volume":"26","author":"Chin","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-[beta] protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat Neurosci"},{"issue":"Suppl. 1","key":"10.1016\/j.neuroscience.2014.11.051_b0100","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.eplepsyres.2005.07.016","article-title":"Epidemiological and medical aspects of epilepsy in the elderly","volume":"68","author":"Cloyd","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0105","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1523\/JNEUROSCI.2325-12.2013","article-title":"Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"33","author":"Corbett","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0110","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u0152\u2a7d-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/neuonc\/nos288","article-title":"Levetiracetam improves verbal memory in high-grade glioma patients","volume":"15","author":"de Groot","year":"2013","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2004.05.107","article-title":"Increased seizure threshold and severity in young transgenic CRND8 mice","volume":"367","author":"Del Vecchio","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0130","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/archneur.57.10.1454","article-title":"Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease","volume":"57","author":"Devi","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nlm.2013.02.001","article-title":"Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer\u2019s disease in mice","volume":"102","author":"Devi","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00406-004-0467-4","article-title":"Prominent behavioural and psychiatric symptoms in early-onset Alzheimer\u2019s disease in a sib pair with the presenilin-1 gene R269G mutation","volume":"254","author":"Doran","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1212\/01.WNL.0000149761.70566.3E","article-title":"An African American family with early-onset Alzheimer disease and an APP (T714I) mutation","volume":"64","author":"Edwards-Lee","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0150","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.52.3.566","article-title":"A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures","volume":"52","author":"Ezquerra","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0155","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archneur.60.8.1149","article-title":"A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease","volume":"60","author":"Ezquerra","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.yebeh.2003.09.007","article-title":"Use of levetiracetam in a population of patients aged 65years and older: a subset analysis of the KEEPER trial","volume":"4","author":"Ferrendelli","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0165","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0170","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.88.8.3363","article-title":"Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease","volume":"88","author":"Flood","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1528-1157.1996.tb00017.x","article-title":"Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study","volume":"37","author":"Forsgren","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0180","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.0572-14.2014","article-title":"Genetic modulation of soluble A\u03b2 rescues cognitive and synaptic impairment in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Fowler","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-510X(02)00466-5","article-title":"A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer\u2019s disease with myoclonus and generalized convulsion","volume":"209","author":"Furuya","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1460-9568.2008.06398.x","article-title":"Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway","volume":"28","author":"Gakhar-Koppole","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0195","doi-asserted-by":"crossref","first-page":"e80706","DOI":"10.1371\/journal.pone.0080706","article-title":"Modeling Alzheimer\u2019s disease in mouse without mutant protein overexpression: cooperative and independent effects of A\u03b2 and Tau","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0200","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1074\/jbc.M111.315051","article-title":"Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives","volume":"287","author":"Guo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0205","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.neurobiolaging.2012.01.002","article-title":"Central CRF system perturbation in an Alzheimer\u2019s disease knockin mouse model","volume":"33","author":"Guo","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0210","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.36.9.1226","article-title":"Seizures and myoclonus in patients with Alzheimer\u2019s disease","volume":"36","author":"Hauser","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/WNL.46.3.727","article-title":"Dementia and adult-onset unprovoked seizures","volume":"46","author":"Hesdorffer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1755-5949.2010.00221.x","article-title":"The upside of APP at synapses","volume":"18","author":"Hoe","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0225","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","article-title":"Increased expression of the amyloid precursor \u03b2-secretase in Alzheimer\u2019s disease","volume":"51","author":"Holsinger","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3940(01)02254-6","article-title":"A novel presenilin mutation (M233V) causing very early onset Alzheimer\u2019s disease with Lewy bodies","volume":"313","author":"Houlden","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0896-6273(95)90107-8","article-title":"Age-related CNS disorder and early death in transgenic FVB\/N mice overexpressing Alzheimer amyloid precursor proteins","volume":"15","author":"Hsiao","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0245","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/ana.410400614","article-title":"The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients","volume":"40","author":"Ikeda","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0250","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archneurol.2011.830","article-title":"Incidence of new-onset seizures in mild to moderate Alzheimer disease","volume":"69","author":"Irizarry","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0255","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/WAD.0b013e31819fe7bd","article-title":"A case series of epilepsy-derived memory impairment resembling Alzheimer disease","volume":"23","author":"Ito","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0260","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000000240","article-title":"Contribution of Alzheimer disease to mortality in the United States","author":"James","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","article-title":"Early onset familial Alzheimer\u2019s disease mutation frequency in 31 families","volume":"60","author":"Janssen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0270","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the \u03b2 amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0275","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/brain\/awq033","article-title":"Alzheimer\u2019s disease phenotypes and genotypes associated with mutations in presenilin 2","volume":"133","author":"Jayadev","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0280","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/nbdi.2002.0557","article-title":"Long-term potentiation is increased in the CA1 area of the hippocampus of APP(swe\/ind) CRND8 mice","volume":"11","author":"Jolas","year":"2002","journal-title":"Neuorobiol Dis"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0285","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"issue":"Pt. 2","key":"10.1016\/j.neuroscience.2014.11.051_b0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/brain\/116.2.309","article-title":"Familial Alzheimer\u2019s disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine\u2192glycine)","volume":"116","author":"Kennedy","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0195-21","article-title":"The Alzheimer\u2019s A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice","volume":"9","author":"LaFerla","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0300","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","article-title":"A prospective study of Alzheimer disease in Down syndrome","volume":"46","author":"Lai","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2004.06.020","article-title":"Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen","volume":"157","author":"Lalonde","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-009-8076-z","article-title":"Epileptic seizures in AD patients","volume":"12","author":"Larner","year":"2009","journal-title":"NeuroMol Med"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2006.11.013","article-title":"The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer\u2019s disease","volume":"252","author":"Larner","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0320","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1073\/pnas.1012568107","article-title":"Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2007.11.021","article-title":"Atypical early-onset Alzheimer\u2019s disease caused by the Iranian APP mutation","volume":"268","author":"Lindquist","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0330","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1531-8249(200009)48:3<376::AID-ANA13>3.0.CO;2-U","article-title":"Familial Alzheimer\u2019s disease: site of mutation influences clinical phenotype","volume":"48","author":"Lippa","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0335","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archneur.59.11.1759","article-title":"Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain","volume":"59","author":"Lle\u00f3","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1567205011310030005","article-title":"Valproic acid attenuates neuronal loss in the brain of APP\/PS1 double transgenic Alzheimer\u2019s disease mice model","volume":"10","author":"Long","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11065-007-9043-9","article-title":"Neuropsychological and behavioral effects of antiepilepsy drugs","volume":"17","author":"Loring","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0350","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000093664","article-title":"Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer\u2019s disease","volume":"22","author":"Lozsadi","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0355","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jnen\/63.3.199","article-title":"Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene","volume":"63","author":"Marcon","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0360","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.41.1.62","article-title":"Early-onset Alzheimer\u2019s disease in 2 large Belgian families","volume":"41","author":"Martin","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0365","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0370","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/seiz.2001.0587","article-title":"Transient epileptic amnesia: an under-diagnosed phenomenon? Three more cases","volume":"11","author":"Mendes","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0375","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002512-200320110-00001","article-title":"Seizures in elderly patients with dementia: epidemiology and management","volume":"20","author":"Mendez","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0380","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","article-title":"Amyloid \u03b2-induced neuronal hyperexcitability triggers progressive epilepsy","volume":"29","author":"Minkeviciene","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0385","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","article-title":"Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain","volume":"274","author":"Moechars","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0390","doi-asserted-by":"crossref","first-page":"33012","DOI":"10.1074\/jbc.M203193200","article-title":"Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer\u2019s disease-causing mutation","volume":"277","author":"Mohajeri","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0395","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-0004.1998.tb02597.x","article-title":"Presenilin 1 Met146Leu variant due to an A&T transversion in an early-onset familial Alzheimer\u2019s disease pedigree from Argentina","volume":"53","author":"Morelli","year":"1998","journal-title":"Clin Genet"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0400","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2011-111928","article-title":"Hormesis and amyloid-beta protein: physiology or pathology?","volume":"29","author":"Morley","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0405","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of A\u03b21-42 in wild-type human amyloid protein precursor transgenic mice: synaptoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0410","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","article-title":"APP binds DR6 to trigger axon pruning and neuron death via distinct caspases","volume":"457","author":"Nikolaev","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0415","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ncomms1781","article-title":"Soluble amyloid precursor protein-\u03b1 modulates \u03b2-secretase activity and amyloid-\u03b2 generation","volume":"3","author":"Obregon","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0420","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0425","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0430","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0435","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse formation and function is modulated by the amyloid precursor protein","volume":"26","author":"Priller","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0440","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory","volume":"69","author":"Puzzo","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0445","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0450","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jnnp.72.2.266","article-title":"A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer\u2019s disease and marked behavioural disturbances","volume":"72","author":"Queralt","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002093-200010000-00008","article-title":"Transient epileptic amnesia in dementia: a treatable unrecognized cause of episodic amnestic wandering","volume":"14","author":"Rabinowicz","year":"2000","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0460","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archneur.1987.00520130042015","article-title":"The electroencephalogram in Alzheimer-type dementia. A sequential study correlating the electroencephalogram with psychometric and quantitative pathologic data","volume":"44","author":"Rae-Grant","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0465","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0470","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archneur.1990.00530080029006","article-title":"Advanced Alzheimer\u2019s disease is a risk factor for late-onset seizures","volume":"47","author":"Romanelli","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0475","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.1993.tb23052.x","article-title":"Alzheimer\u2019s disease families with amyloid precursor protein mutations","volume":"695","author":"Rossor","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0480","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy A randomized study of gabapentin, lamotrigine, and carbamazepine","volume":"64","author":"Rowan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0485","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","author":"Saito","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0490","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0495","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1523\/JNEUROSCI.4917-08.2009","article-title":"Expression of human amyloid precursor protein in rat cortical neurons inhibits calcium oscillations","volume":"29","author":"Santos","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0500","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archneurol.2009.130","article-title":"Seizures in Alzheimer disease: who, when, and how common?","volume":"66","author":"Scarmeas","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0505","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5698\/1535-7511-12.5.178","article-title":"\u201cUntangling\u201d Alzheimer\u2019s disease and epilepsy","volume":"12","author":"Scharfman","year":"2012","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0510","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0515","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.genom.3.022502.103022","article-title":"Deciphering the genetic basis of Alzheimer\u2019s disease","volume":"3","author":"Selkoe","year":"2002","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0520","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awl203","article-title":"APP duplication is sufficient to cause early onset Alzheimer\u2019s dementia with cerebral amyloid angiopathy","volume":"129","author":"Sleegers","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archneur.62.12.1821","article-title":"Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life","volume":"62","author":"Snider","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0530","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0535","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-0404.1982.tb03117.x","article-title":"Alzheimer\u2019s disease and senile dementia of Alzheimer type","volume":"65","author":"Sulkava","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0540","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/emmm.201100195","article-title":"\u03b2-but not \u03b3-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia","volume":"4","author":"Tamayev","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0545","first-page":"208","article-title":"Alzheimer\u2019s disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0550","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1212\/WNL.59.5.779","article-title":"Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome","volume":"59","author":"Tsiouris","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0555","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.0013-9580.2004.55403.x","article-title":"CA1 hippocampal neuronal loss in familial Alzheimer\u2019s disease presenilin-1 E280A mutation is related to epilepsy","volume":"45","author":"Velez-Pardo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0560","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0565","article-title":"Abnormal neuronal networks and seizures susceptibility in mice overexpressing the APP intracellular domain","volume":"5","author":"Vogt","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0570","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0575","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers\u2013a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(02)02617-3","article-title":"Alteration of cortical EEG in mice carrying mutated human APP transgene","volume":"943","author":"Wang","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0585","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/mp.2012.122","article-title":"What\u2019s hAPPening at synapses? The role of amyloid beta-protein precursor and beta-amyloid in neurological disorders","volume":"18","author":"Westmark","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0590","first-page":"157","article-title":"Seizure susceptibility and mortality in mice that over-express amyloid precursor protein","volume":"1","author":"Westmark","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0595","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00001756-199801260-00008","article-title":"Frangione B (A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer\u2019s disease and leads to death as early as the age of 28years","volume":"9","author":"Wisniewski","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0600","doi-asserted-by":"crossref","first-page":"15660","DOI":"10.1523\/JNEUROSCI.4104-09.2009","article-title":"Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity","volume":"29","author":"Yang","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0605","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated [beta]-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0610","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1523\/JNEUROSCI.4701-07.2007","article-title":"A critical function for amyloid precursor protein in neuronal migration revealed by in utero RNA interference","volume":"27","author":"Young-Pearse","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0615","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-6-27","article-title":"Biology and pathophysiology of the amyloid precursor protein","volume":"6","author":"Zheng","year":"2011","journal-title":"Mol Neurodegen"},{"key":"10.1016\/j.neuroscience.2014.11.051_b0620","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eplepsyres.2011.01.003","article-title":"Spontaneous epileptiform discharges in a mouse model of Alzheimer\u2019s disease are suppressed by antiepileptic drugs that block sodium channels","volume":"94","author":"Ziyatdinova","year":"2011","journal-title":"Epilepsy Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452214010197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452214010197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T00:39:22Z","timestamp":1566088762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452214010197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":124,"alternative-id":["S0306452214010197"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2014.11.051","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}